MODIFICATION
R -- Data Coordinating Center (DCC) for Clinical Proteomic Tumor Analysis Consortium (CPTAC) Program
- Notice Date
- 5/26/2016
- Notice Type
- Modification/Amendment
- NAICS
- 541511
— Custom Computer Programming Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- HHS-NIH-NCI-SBSS-TSB-67005-16
- Point of Contact
- Nicole Belanger, Phone: 301 624 8754, Lynne Schneider, Phone: 3016248746
- E-Mail Address
-
belangern@mail.nih.gov, lynne.schneider@nih.gov
(belangern@mail.nih.gov, lynne.schneider@nih.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Amendment #1- The purpose of this amendment is to correct the proposal due date in FBO. This was showing at March 19, 2016, and it is now corrected to June 17, 2016, at 2 PM EDT. The due date has not been changed since the original posting of the Solicitation; the only things that have been changed is the FBO field. Presolicitation Notice: RFP No. N02CO67005-16 Contracting Office Address: Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI), Office of Acquisitions, Riverside Five, Suite 400, 8490 Progress Drive, Room 4035, Frederick, MD 21701-4998. Note: This synopsis follows a Sources Sought notice that was released on 1/06/2016 under HHS-NIH-NCI-SBSS-TSB-67005-16. Description: The National Institutes of Health (NIH), Office of the Director (OD) of the Center for Strategic Scientific Initiatives (CSSI) of the Office of Cancer Clinical Proteomics Research (OCCPR) of the National Cancer Institute (NCI) is seeking a Data Coordinating Center (DCC) in support of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Program. The National Cancer Institute is expanding its basic and translational research programs that rely heavily on sufficient availability of high quality well annotated biospecimens suitable for concurrent use in proteomic and genomic studies. The NCI’s overarching goal with such programs is to improve the ability to diagnose, treat, and prevent cancer. The Clinical Proteomic Tumor Analysis Consortium (CPTAC), one such program, is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of proteomic and genomic technologies. The National Cancer Institute (NCI) launched CPTAC as a technology assessment program in 2006. In its second phase, CPTAC provided proteomic analysis to selected biospecimens from The Cancer Genome Atlas (TCGA). Now in its third phase, CPTAC will expand the depth of analysis and breadth of tumor types to systematically explore the entire spectrum of proteomic and genomic changes involved in human cancer. Specifically, the project is designed to comprehensively analyze protein, RNA, and DNA sequences, DNA copy number changes, protein and transcription profiles, sequence variation, and sequence in both tumor tissue and case-matched germline DNA. The suite of analysis platforms will be applied to a common set of molecular analytes obtained from clinically annotated, high-quality, tumor biospecimens and case-matched nonmalignant tissue. More detailed information can be found at the project’s website: http://proteomics.cancer.gov. To successfully generate comprehensive data, CPTAC will need in excess of 4,000 biospecimens over the course of the project. During its second phase CPTAC generated 20 terabytes (TB) of data, spanning biospecimen information, patient information, and proteome, genome, exome and epigenetic data for both tumor and normal specimens per patient. The ability to ensure data completeness associated with each specimen required a coordinated effort across numerous institutions and information systems. This coordination will become increasingly difficult and important as the program triples the number of tumor types in the coming five years. The purpose of the DCC is to collect, analyze, review, store and distribute the data associated with CPTAC. The rest of this statement of work document outlines the purpose, requirements and scope of the CPTAC DCC. Request for Proposal (RFP) N02CO67005-16 will be available on or about March 22, 2016 and receipt of proposals will be due at 2:00 p.m., Eastern Prevailing Time on or about April 22, 2016. The RFP will only be available electronically and must be accessed through the FedBizOpps website ( www.fbo.gov ) and the National Cancer Institute homepage at http://rcb.cancer.gov/rcb-internet/index.jsp. All information required for submission of a proposal will be contained in the electronic RFP package. It is the offeror’s responsibility to monitor the above Websites for the release of this RFP and amendments, if any. All responsible sources may submit a proposal, which shall be considered by the agency. This notice does not commit the Government to award a contract. Collect calls will not be accepted. Facsimile transmissions will not be accepted. This solicitation is anticipated to result in one (1) award to an offeror capable of performing all aspects of the work described in the Statement of Work (SOW). It is anticipated that a single award, cost-plus-fixed-fee contract will be awarded on or before September 1, 2016, for a base period of one-year, plus four (4) successive one-year option periods. This advertisement does not commit the Government to award any contract. The North American Industry Classification System (NAICS) code is 541511, with a size standard of $27.5 million. This is a new requirement through the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Program. POTENTIAL OFFERORS WILL BE RESPONSBILE FOR DOWNLOADING THEIR OWN COPY OF THE RFP AND ANY POSSIBLE AMENDMENTS, FAILURE TO DO SO WILL BE AT YOUR FIRM’S OWN RISK. ALL INQUIRIES SHALL BE SUBMITTED ELECTRONICALLY TO THE CONTRACTING OFFICER LISTED AS THE POINT OF CONTACT HEREIN. Point of Contact: Nicole Belanger, Contracting Officer; Phone: 301-624-8754; Email: belangern@mail.nih.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/HHS-NIH-NCI-SBSS-TSB-67005-16/listing.html)
- Place of Performance
- Address: Contractor's Facilities, United States
- Record
- SN04130632-W 20160528/160526234845-7e8e27537a5fb3d4f77a586a6cfee860 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |